20th Annual Report of the Company for the Financial Year 2025-26 along with Notice to the Shareholders for Annual General Meeting

MedPlus Health Services Limited July 23, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex, Dalal Street, Fort, Mumbai 400 001 Bandra (East), Mumbai – 400 051 Scrip Code: 543427 Symbol: MEDPLUS Dear Sir/Madam, Subject: 20th Annual Report of the Company for the Financial Year 2025-26 along with Notice to the Shareholders for Annual General Meeting. Further to our letter dated May 20, 2026, we would like to inform that 20th Annual General Meeting of the Company is scheduled to be held on Monday, August 17, 2026 at 03:30 P.M. (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). Pursuant to Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable provisions if any, please find the enclosed herewith Annual Report for Financial Year 2025-26 along with Notice of the 20th Annual General Meeting of the company, which is simultaneously sent to the shareholders through electronic mode. The schedule of remote e-voting is set-out below: Cut-off Date for E-voting Monday, August 10, 2026 E-voting Start Date and Time Friday, August 14, 2026, at 09:00 A.M. E-voting end Date and Time Sunday, August 16, 2026 at 05:00 P.M. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. You are requested to kindly take note of the same. Thanking You Yours faithfully For MedPlus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer (M. No. F12400) Enclosed: a/a 040-6724 6724 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com 2025-26 ANNUAL REPORT Opportunities Growth Progress CORPORATE INFORMATION 02. About us – MedPlus at glance Accelerating 06. Chairman’s Message with Passion. 08. Levers of Growth and Financial Snapshot 12. The Board of Directors Delivering 15. The Management Team 16. Corporate Information with Purpose. STATUTORY REPORT 17. Notice MedPlus offers a 35. Management Discussion and Analysis diverse range of 44. Board’s Report products spanning 69. Corporate Governance Report pharmaceuticals, wellness 91. Business Responsibility and Sustainability Report items, and fast-moving FINANCIAL STATEMENT consumer goods. 125. Standalone Financial Statement 192. Consolidated Financial Statement 2 01 Corporate Statutory Report Financial Statements Overview HO MedPlus at a Glance MedPlus Health Services Limited, commonly known as categories, encompassing pharmaceuticals, wellness MedPlus, stands as a prominent entity in India’s retail items, and fast-moving consumer goods (FMCG). This pharmaceutical landscape. Since its inception in 2006, comprehensive range includes essential items such Opportunities: the company embarked on a mission to establish a retail as medications, vitamins, medical devices, home and pharmaceutical brand that not only provides authentic personal care products, toiletries, baby care essentials, MedPlus recognized the national issue of counterfeit drugs and medications as a chance to make a positive impact. medicines but also enhances value for its customers soaps, detergents, as well as sanitizers, among various To tackle these concerns and provide reassurance to the people of India, MedPlus embarked on its journey as through technology-driven supply chain efficiencies. products. an organized retail entity. The primary goal was to establish a streamlined process where medicines and various The company’s product portfolio spans across diverse products could be sourced directly from manufacturers and efficiently delivered to customers in their local communities. This approach was carefully designed to offer customers maximum value while addressing the genuine worries surrounding the authenticity of drugs. In addition to combating the issue of counterfeit drugs, MedPlus ensured that the medications it provided were stored under optimal conditions, further enhancing the quality and safety of the products available to its customers Growth: MedPlus started in 2006 with 48 stores in Hyderabad, Now MedPlus is offering its services in 13 states and one union territory through 5,330 stores which are spread across Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, Delhi, Uttar Pradesh, Haryana and Puducherry. MedPlus employs a data analytics driven cluster- based process to expand its store network. The cluster-based approach to store network expansion is also driven by our understanding of the catchment demographics, market dynamics, and our ability to support store expansion with back- end infrastructure, such as warehouses and distribution centres. This approach allow us to:  Increase our market share in the cities where we operate,  Replicate our growth model in adjacent underserved cities and towns, as we develop our presence in those clusters,  Generate cost efficiencies due to operating leverage achieved in our supply chain and inventory management,  Create brand visibility within the cities where we operate, through focused implementation of marketing and advertising initiatives Our cluster-based expansion approach and replicable store roll- out strategy have allowed us to achieve and maintain attractive and healthy store level economics Progress: During the year under review a net total of 618 new stores were opened across cities. 02 03 MedPlus Health Services Limited Annual Report 2025-26 Corporate Statutory Report Financial Statements Overview HO Our Potential in Numbers 20 2nd years of Distinguished presence Largest Pharma retailer in India Geographical Presence 13 1 states, Union territory Over 5,330 Physical Stores Cities Over 28,000+ 50,000 Team strength SKUs Pharma & Non-pharma The first in the country to establish an omnichannel presence, combining both digital and neighbourhood stores 850+ Private Label Products Including Chronic, OTC & Other pharma products 700+ Private Label Products covered in the non-pharma segment, including packaged food, daily essentials, baby products, cleaning products, cosmetics, and toiletries 04 05 MedPlus Health Services Limited Annual Report 2025-26 Corporate Statutory Report Financial Statements Overview HO urban areas. There are gaps across push the boundaries of healthcare awareness, access, affordability and delivery and set new benchmarks for acceptability of product and services excellence. Chairman’s Message During the financial year: Our achievements would not be possible without our dedicated l We registered H 68,924.66 employees. I thank you for your million revenue from operations passion and commitment. Your Company continues in 2025- 26, recording a 12.33% growth as compared to the In embracing the challenges and to focus on providing previous year’s revenue of H opportunities that lie ahead, let pharmaceuticals, wellness 61,360.53 million. us stand united, bound by our Dear Shareholders, shared vision and the unwavering items and fast-moving l Our PAT stood at H 2,196.06 support that has brought us this far. As we reflect on the past twenty million in 2025-26, compared to consumer goods guided by With a heart full of gratitude, I look years, we can proudly acknowledge the previous year PAT of H 1502.33 forward to the continued journey of the three core principles: the strides we have taken in million. elevating healthcare and enriching delivering value to all stakeholders. lives together. Our reach now extends to over 800 As we navigate the future, we  Providing genuine products cities across Telangana, Andhra remain committed to our core Thanks, Pradesh, Karn [Showing first 8,000 characters — download PDF for full document]